Ledger.Open graph →
SEC Form D · filed January 17, 2025

KAZIA THERAPEUTICS LTD

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Sydney, Channel Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ebru Davidson · Sydney, Channel IslandsDirectorBryce Carmine · Sydney, Channel IslandsDirectorSteven Coffey · Sydney, Channel IslandsDirectorJeffrey Bonacorda · Sydney, Channel IslandsExecElissa Hansen · Sydney, Channel IslandsExecRobert Apple · Sydney, Channel IslandsDirectorJohn Friend · Sydney, Channel IslandsExec · DirectorEbru Davidson · Sydney, Channel IslandsDirectorBryce Carmine · Sydney, Channel IslandsDirectorSteven Coffey · Sydney, Channel IslandsDirectorElissa Hansen · Sydney, Channel IslandsExecJeffrey Bonacorda · Sydney, Channel IslandsExecJohn Friend · Sydney, Channel IslandsExec · DirectorRobert Apple · Sydney, Channel IslandsDirectorJames Ruggerio · Chatham, NJDirectorCraig Stilwell · Osceola, IAExec · DirectorRobert Taylor · Osceola, IAExecChristina Taylor · Osceola, IADirectorChad Terry · Osceola, IADirectorTodd G. Rapp · New York, NYDirectorJeff G. Runnfeldt · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗